Tabernanthine, ibogaine containing analgesic compositions
First Claim
Patent Images
1. A NEW ANALGESIC COMPOSITION CONTAINING A MEMBER SELCETED FROM THE GROUP CONSISTING OF MORPHINE, CODEINE DIHYDROMORPHINONE, METHYL-DIHYDROMORPHINONE, PANTOPON, ETHYLOMORPHINE., KETOBEMIDON, MEPERIDINE, DIHYDROCODEINONE, DIHYDROMORPHINE, DIHYSO-DESOXYMORPHINE-D DIHYDO-DESOXYCODEINE - D, D,1-3METHOXY-N-METHYLMORPHINAN, DI,1-3-HYDROXY-N-METHYLMORPHINAN AND THE THERAPEUTICALLY ACTIVE SALTS THEREOF AND AN INDOLE ALKALOID SELECTED FROM THE GROUP CONSISTING OF IBOGAINE, TABERNATHINE AND THEIR THERAPEUTICALLY ACTIVE SALT, THE RATIO BETWEEN THE INDOLE ALKALOID:
- MORPHINE COMPONENT BEING FROM ABOUT 0.5 TO ABOUT 20.0, TO 1.
0 Assignments
0 Petitions
Accused Products
8 Citations
1 Claim
-
1. A NEW ANALGESIC COMPOSITION CONTAINING A MEMBER SELCETED FROM THE GROUP CONSISTING OF MORPHINE, CODEINE DIHYDROMORPHINONE, METHYL-DIHYDROMORPHINONE, PANTOPON, ETHYLOMORPHINE., KETOBEMIDON, MEPERIDINE, DIHYDROCODEINONE, DIHYDROMORPHINE, DIHYSO-DESOXYMORPHINE-D DIHYDO-DESOXYCODEINE - D, D,1-3METHOXY-N-METHYLMORPHINAN, DI,1-3-HYDROXY-N-METHYLMORPHINAN AND THE THERAPEUTICALLY ACTIVE SALTS THEREOF AND AN INDOLE ALKALOID SELECTED FROM THE GROUP CONSISTING OF IBOGAINE, TABERNATHINE AND THEIR THERAPEUTICALLY ACTIVE SALT, THE RATIO BETWEEN THE INDOLE ALKALOID:
- MORPHINE COMPONENT BEING FROM ABOUT 0.5 TO ABOUT 20.0, TO 1.
Specification